Show simple item record

dc.contributor.authorElman, Jessica S
dc.contributor.authorShen, Keyue
dc.contributor.authorGabow, Aaron
dc.contributor.authorYarmush, Joshua
dc.contributor.authorJiao, Yunxin
dc.contributor.authorFletcher, Anne
dc.contributor.authorLee, Jungwoo
dc.contributor.authorYarmush, Martin L
dc.contributor.authorParekkadan, Biju
dc.contributor.authorLi, Matthew
dc.contributor.authorManrai, Arjun Kumar
dc.contributor.authorMilwid, Jack
dc.contributor.authorCima, Michael J.
dc.date.accessioned2017-10-05T17:15:39Z
dc.date.available2017-10-05T17:15:39Z
dc.date.issued2016-12
dc.date.submitted2013-07
dc.identifier.issn1525-0016
dc.identifier.issn1525-0024
dc.identifier.urihttp://hdl.handle.net/1721.1/111793
dc.description.abstractThe secreted proteins from a cell constitute a natural biologic library that can offer significant insight into human health and disease. Discovering new secreted proteins from cells is bounded by the limitations of traditional separation and detection tools to physically fractionate and analyze samples. Here, we present a new method to systematically identify bioactive cell-secreted proteins that circumvent traditional proteomic methods by first enriching for protein candidates by differential gene expression profiling. The bone marrow stromal cell secretome was analyzed using enriched gene expression datasets in combination with potency assay testing. Four proteins expressed by stromal cells with previously unknown anti-inflammatory properties were identified, two of which provided a significant survival benefit to mice challenged with lethal endotoxic shock. Greater than 85% of secreted factors were recaptured that were otherwise undetected by proteomic methods, and remarkable hit rates of 18% in vitro and 9% in vivo were achieved. © 2014 The American Society of Gene and Cell Therapy.en_US
dc.description.sponsorshipNational Human Genome Research Institute (U.S.) (Grant T32 HG002295)en_US
dc.publisherElsevier BVen_US
dc.relation.isversionofhttp://dx.doi.org/10.1038/MT.2014.17en_US
dc.rightsCreative Commons Attribution-NonCommercial-NoDerivs Licenseen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/en_US
dc.sourceElsevieren_US
dc.titleEnriched Protein Screening of Human Bone Marrow Mesenchymal Stromal Cell Secretions Reveals MFAP5 and PENK as Novel IL-10 Modulatorsen_US
dc.typeArticleen_US
dc.identifier.citationMilwid, Jack M et al. “Enriched Protein Screening of Human Bone Marrow Mesenchymal Stromal Cell Secretions Reveals MFAP5 and PENK as Novel IL-10 Modulators.” Molecular Therapy 22, 5 (May 2014): 999–1007 © The American Society of Gene & Cell Therapyen_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technologyen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Materials Science and Engineeringen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorMilwid, Jack Miles
dc.contributor.mitauthorLi, Matthew
dc.contributor.mitauthorManrai, Arjun Kumar
dc.contributor.mitauthorCima, Michael J
dc.relation.journalMolecular Therapyen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2017-10-05T13:03:04Z
dspace.orderedauthorsMilwid, Jack M; Elman, Jessica S; Li, Matthew; Shen, Keyue; Manrai, Arjun; Gabow, Aaron; Yarmush, Joshua; Jiao, Yunxin; Fletcher, Anne; Lee, Jungwoo; Cima, Michael J; Yarmush, Martin L; Parekkadan, Bijuen_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0001-9296-2220
dc.identifier.orcidhttps://orcid.org/0000-0003-2379-6139
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record